TipRanks on MSN

Ceribell, Inc. Reports Strong Q3 Growth Amid Challenges

Ceribell, Inc. (($CBLL)) has held its Q3 earnings call. Read on for the main highlights of the call. Ceribell, Inc. recently held its earnings ...
The Manila Times

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s frequency neurostimulator as a potential non-invasive therapy for cognitive disor ...
Healio

Q&A: Understanding OSA treatment impact with patient-reported outcome tool

The Patient-reported Longitudinal Assessment Tool for Obstructive sleep apnea, or PLATO, serves as a new questionnaire in ...